Founded in 2023, Vastiva Pharmaceutical is a fast-growing pharmaceutical company committed to improving healthcare through quality, innovation, and trust. Headquartered in Bengaluru, Karnataka, India, we are dedicated to delivering safe, effective, and affordable healthcare solutions that meet the evolving needs of patients and healthcare professionals.
To provide accessible, high-quality pharmaceutical products that improve lives while maintaining the highest standards of ethics, quality, and customer satisfaction.

VITASTIVA 24 is a comprehensive nutraceutical supplement containing 24 essential vitamins, minerals, antioxidants, natural extracts, and amino acids. It helps support energy, immunity, mental focus, and overall well-being, making it an ideal daily nutritional supplement for maintaining an active and healthy lifestyle.

VALCIUM is a scientifically balanced Calcium, Calcitriol, Zinc, and Magnesium supplement formulated to support strong bones, healthy muscles, and overall wellness. It helps improve calcium absorption, maintain bone density, strengthen immunity, and reduce the risk of calcium deficiency, making it ideal for daily bone health support.

VITASTIVA CD3 is a scientifically formulated neuro-vitamin supplement containing Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine (Vitamin B6), and Folic Acid. It supports nerve health, energy production, red blood cell formation, immunity, and overall well-being, making it ideal for individuals with nerve weakness, vitamin deficiencies, and active lifestyles.

ACECLOSTIVA-SP is a powerful triple-action combination of Aceclofenac 100 mg, Serratiopeptidase 15 mg, and Paracetamol 325 mg, designed to provide effective relief from pain, inflammation, swelling, and fever. It promotes faster recovery, improved mobility, and better patient comfort, making it ideal for managing musculoskeletal pain, arthritis, post-operative pain, and sports injuries.

CEFISTIVA 200 is a broad-spectrum Cefixime 200 mg antibiotic formulated to effectively treat a wide range of bacterial infections, including respiratory tract, ENT, urinary tract, skin, and gastrointestinal infections. It provides trusted protection, faster recovery, and excellent clinical efficacy with good patient tolerability.

RABESTIVA-DSR is a clinically proven combination of Rabeprazole 20 mg and Domperidone SR 30 mg, formulated for the effective management of acidity, heartburn, acid reflux, nausea, and gastric discomfort. It provides long-lasting acid suppression, improves gastric motility, and delivers fast, sustained relief, helping restore digestive comfort and overall well-being.

CEFASTIVA-500 is a second-generation Cefuroxime Axetil 500 mg antibiotic that provides broad-spectrum antibacterial coverage against a wide range of bacterial infections, including respiratory tract, ENT, urinary tract, skin, and soft tissue infections. With excellent oral bioavailability and proven clinical efficacy, it ensures effective infection control, faster recovery, and reliable patient outcomes.
To be a leading pharmaceutical company delivering innovative and affordable healthcare solutions that inspire confidence among patients and healthcare professionals.
As we move forward, our goal is to lead the way in pioneering breakthrough pharmaceutical solutions that transcend conventional boundaries. We aim to:……….
“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”

“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”

“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”

“Objectively deploy open-source web-readiness impactful bandwidth. Compellingly coordinate business deliverables rather equity invested technologies. Phosfluorescently reinvent maintainable.”
